{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:07:05Z","timestamp":1788995225208,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":97,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Agence Nationale pour la Recherche","award":["ANR-10-LABX62-IBEID"],"award-info":[{"award-number":["ANR-10-LABX62-IBEID"]}]},{"name":"TBVAC-HORIZON project","award":["101080309"],"award-info":[{"award-number":["101080309"]}]},{"name":"The Canadian Institutes for Health Research (CIHR) Foundation Program"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI181898"],"award-info":[{"award-number":["5P01AI181898"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI181898"],"award-info":[{"award-number":["5P01AI181898"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01498-6","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:13:26Z","timestamp":1780658006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetically diverse CC and DO mouse models enable comprehensive assessments of novel tuberculosis vaccines"],"prefix":"10.1038","volume":"11","author":[{"given":"Rocky","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry L.","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Afkhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Brosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia S.","family":"Lindestam Arlehamn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Elkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Behar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"1498_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00750-7","volume":"8","author":"R Lai","year":"2023","unstructured":"Lai, R., Ogunsola, A. F., Rakib, T. & Behar, S. M. Key advances in vaccine development for tuberculosis-success and challenges. npj Vaccines 8, 158 (2023).","journal-title":"npj Vaccines"},{"key":"1498_CR2","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.4049\/jimmunol.2000563","volume":"205","author":"C Aagaard","year":"2020","unstructured":"Aagaard, C. et al. Immunization with mycobacterium tuberculosis-specific antigens bypasses T cell differentiation from prior bacillus calmette-guerin vaccination and improves protection in mice. J. Immunol. 205, 2146\u20132155 (2020).","journal-title":"J. Immunol."},{"key":"1498_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26934-0","volume":"12","author":"JS Woodworth","year":"2021","unstructured":"Woodworth, J. S. et al. A mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guerin. Nat. Commun. 12, 6658 (2021).","journal-title":"Nat. Commun."},{"key":"1498_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00623-z","volume":"8","author":"S Afkhami","year":"2023","unstructured":"Afkhami, S. et al. Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice. npj Vaccines 8, 25 (2023).","journal-title":"npj Vaccines"},{"key":"1498_CR5","doi-asserted-by":"publisher","unstructured":"Smith, C. M. et al. Tuberculosis susceptibility and vaccine protection are independently controlled by host genotype. MBio 7 https:\/\/doi.org\/10.1128\/mBio.01516-16 (2016).","DOI":"10.1128\/mBio.01516-16"},{"key":"1498_CR6","doi-asserted-by":"publisher","unstructured":"Lai, R. et al. Host genetic background is a barrier to broadly effective vaccine-mediated protection against tuberculosis. J. Clin. Investig. 133 https:\/\/doi.org\/10.1172\/JCI167762 (2023).","DOI":"10.1172\/JCI167762"},{"key":"1498_CR7","doi-asserted-by":"publisher","unstructured":"Kurtz, S. L. et al. The diversity outbred mouse population is an improved animal model of vaccination against tuberculosis that reflects heterogeneity of protection. mSphere 5 https:\/\/doi.org\/10.1128\/mSphere.00097-20 (2020).","DOI":"10.1128\/mSphere.00097-20"},{"key":"1498_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ng1104-1133","volume":"36","author":"GA Churchill","year":"2004","unstructured":"Churchill, G. A. et al. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat. Genet. 36, 1133\u20131137 (2004).","journal-title":"Nat. Genet."},{"key":"1498_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.547","volume":"2","author":"J Hackett","year":"2022","unstructured":"Hackett, J., Gibson, H., Frelinger, J. & Buntzman, A. Using the collaborative cross and diversity outbred mice in immunology. Curr. Protoc. 2, e547 (2022).","journal-title":"Curr. Protoc."},{"key":"1498_CR10","doi-asserted-by":"publisher","unstructured":"Smith, C. M. et al. Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice. eLife 11 https:\/\/doi.org\/10.7554\/eLife.74419 (2022).","DOI":"10.7554\/eLife.74419"},{"key":"1498_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00168-23","volume":"91","author":"SL Kurtz","year":"2023","unstructured":"Kurtz, S. L. et al. Intravenous BCG vaccination of diversity outbred mice results in moderately enhanced protection against challenge with Mycobacterium tuberculosis compared to intradermal vaccination. Infect. Immun. 91, e0016823 (2023).","journal-title":"Infect. Immun."},{"key":"1498_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127347","volume":"61","author":"SL Kurtz","year":"2025","unstructured":"Kurtz, S. L., Gould, V., Flores-Valdez, M. A. & Elkins, K. L. Recombinant BCG\u0394BCG1419c protects outbred mice against M. tuberculosis challenge. Vaccine 61, 127347 (2025).","journal-title":"Vaccine"},{"key":"1498_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03232-25","volume":"17","author":"M Ahmed","year":"2026","unstructured":"Ahmed, M. et al. Targeting the lung innate pathways during tuberculosis can improve vaccine-induced protection via Th17 responses in diversity outbred mice. mBio 17, e0323225 (2026).","journal-title":"mBio"},{"key":"1498_CR14","doi-asserted-by":"publisher","first-page":"e1012069","DOI":"10.1371\/journal.ppat.1012069","volume":"20","author":"SL Kurtz","year":"2024","unstructured":"Kurtz, S. L. et al. Multiple genetic loci influence vaccine-induced protection against Mycobacterium tuberculosis in genetically diverse mice. PLoS Pathog. 20, e1012069 (2024).","journal-title":"PLoS Pathog."},{"key":"1498_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","volume":"577","author":"PA Darrah","year":"2020","unstructured":"Darrah, P. A. et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature 577, 95\u2013102 (2020).","journal-title":"Nature"},{"key":"1498_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fimmu.2018.00121","volume":"9","author":"NE Nieuwenhuizen","year":"2018","unstructured":"Nieuwenhuizen, N. E. & Kaufmann, S. H. E. Next-generation vaccines based on bacille calmette-guerin. Front. Immunol. 9, 121 (2018).","journal-title":"Front. Immunol."},{"key":"1498_CR17","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","volume":"7","author":"H McShane","year":"2005","unstructured":"McShane, H. & Hill, A. Prime-boost immunisation strategies for tuberculosis. Microbes Infect. 7, 962\u2013967 (2005).","journal-title":"Microbes Infect."},{"key":"1498_CR18","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.celrep.2017.02.057","volume":"18","author":"MI Groschel","year":"2017","unstructured":"Groschel, M. I. et al. Recombinant BCG expressing ESX-1 of mycobacterium marinum combines low virulence with cytosolic immune signaling and improved TB protection. Cell Rep. 18, 2752\u20132765 (2017).","journal-title":"Cell Rep."},{"key":"1498_CR19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrmicro.2016.131","volume":"14","author":"MI Groschel","year":"2016","unstructured":"Groschel, M. I., Sayes, F., Simeone, R., Majlessi, L. & Brosch, R. ESX secretion systems: mycobacterial evolution to counter host immunity. Nat. Rev. Microbiol. 14, 677\u2013691 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"1498_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mib.2008.11.003","volume":"12","author":"R Simeone","year":"2009","unstructured":"Simeone, R., Bottai, D. & Brosch, R. ESX\/type VII secretion systems and their role in host-pathogen interaction. Curr. Opin. Microbiol. 12, 4\u201310 (2009).","journal-title":"Curr. Opin. Microbiol."},{"key":"1498_CR21","doi-asserted-by":"publisher","unstructured":"Sayes, F. et al. Improved immune responses and tuberculosis protection by aerosol vaccination with recombinant BCG expressing ESX-1 from Mycobacterium marinum. bioRxiv https:\/\/doi.org\/10.1101\/2025.09.18.677039 (2025).","DOI":"10.1101\/2025.09.18.677039"},{"key":"1498_CR22","first-page":"1141","volume":"8","author":"MK Niazi","year":"2015","unstructured":"Niazi, M. K. et al. Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice. Dis. Model Mech. 8, 1141\u20131153 (2015).","journal-title":"Dis. Model Mech."},{"key":"1498_CR23","doi-asserted-by":"publisher","first-page":"e1005760","DOI":"10.1371\/journal.ppat.1005760","volume":"12","author":"CS Lindestam Arlehamn","year":"2016","unstructured":"Lindestam Arlehamn, C. S. et al. A quantitative analysis of complexity of human pathogen-specific CD4 T cell responses in healthy M. tuberculosis Infected South Africans. PLoS Pathog. 12, e1005760 (2016).","journal-title":"PLoS Pathog."},{"key":"1498_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.76","volume":"2","author":"M Pai","year":"2016","unstructured":"Pai, M. et al. Tuberculosis. Nat. Rev. Dis. Prim. 2, 16076 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1498_CR25","doi-asserted-by":"publisher","unstructured":"Pena, J. C. & Ho, W. Z. Non-human primate models of tuberculosis. Microbiol. Spectr. 4 https:\/\/doi.org\/10.1128\/microbiolspec.TBTB2-0007-2016 (2016).","DOI":"10.1128\/microbiolspec.TBTB2-0007-2016"},{"key":"1498_CR26","doi-asserted-by":"publisher","unstructured":"Miranda-Hernandez, S. et al. CD8(+) T cells sustain vaccination-induced immunity against dissemination of contained tuberculosis in immunosuppressed hosts. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-026-70911-4 (2026).","DOI":"10.1038\/s41467-026-70911-4"},{"key":"1498_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1615\/CritRevImmunol.v26.i4.30","volume":"26","author":"JS Woodworth","year":"2006","unstructured":"Woodworth, J. S. & Behar, S. M. Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity. Crit. Rev. Immunol. 26, 317\u2013352 (2006).","journal-title":"Crit. Rev. Immunol."},{"key":"1498_CR28","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1128\/IAI.70.8.4501-4509.2002","volume":"70","author":"AA Chackerian","year":"2002","unstructured":"Chackerian, A. A., Alt, J. M., Perera, T. V., Dascher, C. C. & Behar, S. M. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 70, 4501\u20134509 (2002).","journal-title":"Infect. Immun."},{"key":"1498_CR29","doi-asserted-by":"publisher","unstructured":"Larsen, M. H., Biermann, K. & Jacobs, W. R., Jr Laboratory maintenance of Mycobacterium tuberculosis. Curr. Protoc. Microbiol. 10, https:\/\/doi.org\/10.1002\/9780471729259.mc10a01s6 (2007).","DOI":"10.1002\/9780471729259.mc10a01s6"},{"key":"1498_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1099\/00222615-30-3-175","volume":"30","author":"T Collins","year":"1989","unstructured":"Collins, T. & Levett, P. N. Radiometric studies on the use of selective inhibitors in the identification of Mycobacterium spp. J. Med. Microbiol. 30, 175\u2013181 (1989).","journal-title":"J. Med. Microbiol."},{"key":"1498_CR31","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1016\/j.vaccine.2008.09.011","volume":"26","author":"SC Derrick","year":"2008","unstructured":"Derrick, S. C. et al. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis. Vaccine 26, 6092\u20136098 (2008).","journal-title":"Vaccine"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01498-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01498-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01498-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:22:21Z","timestamp":1788992541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01498-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01498-6","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.A. and Z.X. are inventors on a published PCT patent application no. PCT\/CA2023\/051523 entitled \u201cTrivalent tuberculosis vaccine,\u201d which describes the ChAd.TB vaccine used in the studies described herein. The other authors do not have a competing interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"179"}}